Ireland is the UK’s fourth largest export market.  It is the only major world market where the UK is the major supplier and the UK is also the third largest investor in Ireland, after the US and Germany.

Ireland presents a wealth of opportunities to UK companies, including:

• A ripe export market for a wide variety of products and services
• Developments in the healthcare sector
• Asset management and fund administration activities
• Emerging renewable energy and “clean tech” sector
• Ongoing construction and infrastructure projects

Tax

Ireland has a business-friendly, common law, corporate tax system, which is in line with OECD norms.  Its low corporate tax rate of 12.5% on trading profits provides the basis for companies to structure trading and holding company operations in Ireland. 

Ireland also has a very beneficial Intellectual Property (“IP”) regime, which facilitates the application of the 12.5% corporate tax rate to profits from the exploitation of IP in Ireland.  Furthermore, to help develop and sustain the Irish knowledge based economy, and to encourage companies which develop, own and exploit their IP from an Irish base, capital allowances are available for capital expenditure incurred on the creation and acquisition of “specified intangible assets”, including the acquisition of IP. 

Our UK based clients cover the spectrum of industries from pharmaceuticals, technology, financial services, healthcare, and includes advising:

RSA Insurance (formerly Royal & Sun Alliance)

Aviva

Duke Street Capital

Shire Pharmaceuticals

BSkyB

HMV

Tesco

Associated Newspapers

Barclays Global Investors

Barclays Wealth